Patents/Assignees

GLAXOSMITHKLINE BIOLOGICALS SA

101 patents in portfolio

US11795478utility2023
Adenovirus Polynucleotides and Polypeptides
0 cites
US11786467utility2023
Lipid Formulations with Immunogens
0 cites
US11773139utility2023
Epstein-barr Virus Antigen Constructs
0 cites
US11773395utility2023
Immunization of Large Mammals with Low Doses of RNA
0 cites
US11766401utility2023
Methods of Administering Lipid Formulations with Immunogens
0 cites
US11759422utility2023
Pegylated Liposomes for Delivery of Immunogen-encoding RNA
0 cites
US11759475utility2023
Delivery of RNA to Trigger Multiple Immune Pathways
0 cites
US11744890utility2023
Saponin Extraction
0 cites
US11739334utility2023
Immunisation of Large Mammals with Low Doses of RNA
0 cites
US11730700utility2023
Lipid Formulations with Viral Immunogens
0 cites
US11730754utility2023
Delivery of RNA to Trigger Multiple Immune Pathways
0 cites
US11723966utility2023
Methods of Boosting Immune Responses
0 cites
US11717529utility2023
Delivery of RNA to Trigger Multiple Immune Pathways
0 cites
US11707482utility2023
Delivery of RNA to Trigger Multiple Immune Pathways
0 cites
US11707513utility2023
Meningococcus Vaccines
0 cites
US11708394utility2023
Modified Meningococcal FHBP Polypeptides
0 cites
US11701422utility2023
Expression Systems
0 cites
US11702674utility2023
Simian Adenovirus Vectors Comprising the Chad-157 Fiber Protein
0 cites
US11696923utility2023
Delivery of RNA to Trigger Multiple Immune Pathways
0 cites
US11690861utility2023
Delivery of RNA to Trigger Multiple Immune Pathways
0 cites

← PreviousPage 4 of 6Next →